How does Enalapril compare to ARBs in managing diabetic nephropathy, and which class is more effective for reducing proteinuria and preserving kidney function?
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Enalapril, an ACE inhibitor, and ARBs both delay progression of diabetic nephropathy. ARBs may be more effective in reducing proteinuria and preserving kidney function.